flurbiprofen has been researched along with ovalbumin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dahlén, SE; Kumlin, M; Låstbom, L; Ryrfeldt, A; Selg, E | 1 |
Che, X; Cui, Y; Han, F; Li, S; Yin, H; Yin, R; Yuan, J | 1 |
2 other study(ies) available for flurbiprofen and ovalbumin
Article | Year |
---|---|
Effects of selective and non-selective COX inhibitors on antigen-induced release of prostanoid mediators and bronchoconstriction in the isolated perfused and ventilated guinea pig lung.
Topics: Animals; Bronchoconstriction; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diclofenac; Flurbiprofen; Guinea Pigs; Humans; Leukotrienes; Lung; Male; Ovalbumin; Piperazines; Prostaglandins; Pyrazoles; Sulfonamides; Thiazoles; Thromboxane A2; Thromboxane B2 | 2008 |
Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Drug Carriers; Edema; Fatty Acids; Flurbiprofen; Gels; In Vitro Techniques; Male; Nanostructures; Ovalbumin; Particle Size; Rats; Rats, Wistar; Skin; Skin Absorption; Skin Irritancy Tests; Surface-Active Agents; Triglycerides | 2012 |